MARKET

AEON

AEON

Aeon Biopharma
AMEX
0.3517
+0.0617
+21.28%
Opening 13:27 09/11 EDT
OPEN
0.2980
PREV CLOSE
0.2900
HIGH
0.3799
LOW
0.2903
VOLUME
26.78M
TURNOVER
--
52 WEEK HIGH
1.450
52 WEEK LOW
0.1772
MARKET CAP
17.54M
P/E (TTM)
-0.0981
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 20h ago
5 Biotech Stocks In Spotlight: Tenon Medical, AEON Biopharma, Silexion, Orchestra BioMed & Indaptus
NASDAQ · 23h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 1d ago
AEON Reports Comparable Forced Degradation Results For ABP-450 In Pilot Study; Stock Up
NASDAQ · 1d ago
Why AeroVironment Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 1d ago
Aeon Biopharma announces results from ABP-450 pilot forced degradation study
TipRanks · 2d ago
More
About AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.

Webull offers Aeon Biopharma Inc stock information, including AMEX: AEON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEON stock methods without spending real money on the virtual paper trading platform.